You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 5,582,973


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,582,973
Title: Sensitive method for localizing chromosomal breakpoints
Abstract:A sensitive method for identifying chromosomal breakpoints flanked by repeat sequences, through amplification by polymerase chain reaction, is described. The application of the method to the detection of Burkitt\'s lymphoma cells is demonstrated.
Inventor(s): Magrath; Ian T. (Silver Spring, MD), Shiramizu; Bruce (Pacifica, CA)
Assignee: The United States of America as represented by the Department of Health (Washington, DC)
Application Number:08/160,547
Patent Claims:1. A method for localizing breakpoints between human chromosome 8 and chromosomes 14 or 22 when involved in a translocation between the chromosomes using a polymerase chain reaction, the method comprising the steps of:

(a) preparing a PCR mixture having:

(i) a segment of nucleic acid having a portion of chromosome 8 and a portion of chromosome 14 or 22 and

(ii) a PCR primer pair of at least two members in which a first member binds to a portion of the c-myc gene of chromosome 8 and the second member binds to a repeat region within a gene encoding an immunoglobin chain on chromosome 14 or 22;

(b) conducting a PCR amplification of the segment of nucleic acid; and,

(c) identifying the presence of the amplified segment of step (b) using a labeled probe,

thereby localizing said breakpoint between human chromosome 8 and chromosomes 14 or 22.

2. A method of claim 1 wherein the first member of the PCR primer pair binds to the first intron of c-myc.

3. A method of claim 1 wherein the first member of the primer pair binds to the first exon of c-myc.

4. A method of claim 1 wherein the second member of the primer pair binds to a repeat region within a member of the group consisting of a heavy chain region of chromosome 14, a Lambda-variable loci of chromosome 22 and a Lambda-constant loci of chromosome 22.

5. A method of claim 4 wherein the second member of the primer pair binds to a repeat region within a heavy chain switch region of chromosome 14.

6. A method of claim 5 wherein the second member of the primer pair binds to a repeat region in the Switch-mu loci.

7. A method of claim 5 wherein the second member of the primer pair binds to a repeat region in the Switch-alpha loci.

8. A method of claim 5 wherein the second member of the primer pair binds to a repeat region in the Switch-gamma loci.

9. A method of claim 4 wherein the second member of the primer pair binds to a repeat region in a J-Heavy loci.

10. A method of claim 3 wherein the second member of the primer pair binds to a repeat region in Switch-mu region of chromosome 14.

11. A PCR reaction mixture for localizing breakpoints in between human chromosome 8 and chromosomes 14 and 22 when involved in a translocation between the chromosomes the mixture comprising a PCR primer pair of at least two members in which the first member binds to a portion of the c-myc gene of chromosome 8 and the second member binds to a repeat region within a gene encoding an immunoglobin chain on chromosome 14 or 22.

12. A mixture of claim 11 wherein the first member of the primer pair binds to the first intron of c-myc.

13. A mixture of claim 11 wherein the first member of the primer pair binds to the first exon of c-myc.

14. A mixture of claim 11 wherein the second member binds to a member of the group consisting of a heavy chain region of chromosome 14, a Lambda-variable loci of chromosome 22 and a Lambda-constant loci of chromosome 22.

15. A mixture of claim 11 wherein the second member of the primer pair binds to a repeat region within a heavy chain switch region of chromosome 14.

16. A mixture of claim 15 wherein the second member of the primer pair binds to a repeat region in the Switch-mu loci.

17. A mixture of claim 15 wherein the second member of the primer pair binds to a repeat region in the Switch-alpha loci.

18. A mixture of claim 15 wherein the second member of the primer pair binds to a repeat region in the Switch-gamma loci.

19. A mixture of claim 14 wherein the second member of the primer pair binds to a repeat region in a J-Heavy loci.

20. A mixture of claim 13 wherein the second member of the primer pair binds to a repeat region in Switch-mu region of chromosome 14.

Details for Patent 5,582,973

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2013-12-10
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2013-12-10
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2013-12-10
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.